Efficacy Study of a Neuropsychological Rehabilitation Intervention for Children With Non-symptomatic Epilepsy
Studio di Efficacia di Percorsi di Riabilitazione Neuropsicologica Tramite Piattaforma Lumosity: Evidenze Comportamentali e Neurofisiologiche in Pazienti Con Epilessia Non Sintomatica in età Pediatrica
1 other identifier
interventional
48
0 countries
N/A
Brief Summary
Patients with non-symptomatic epilepsy, even in the presence of a normative cognitive functioning, present different levels of neuropsychological weaknesses, especially in executive functions and social competences. Such difficulties can significantly influence academic achievement and social inclusion. To date, there is limited evidence on small samples that training focusing on executive functions, also through tele-rehabilitation methods, may be effective in limiting these difficulties. Therefore, the purpose of this research project is to evaluate the effectiveness of a training of the executive functions (administered via the Lumosity platform) in patients with non-symptomatic focal and generalized epilepsy. A cognitive and behavioral assessment will be performed before and after the treatment to evaluate its efficacy. Moreover, a predefined neurophysiological marker will be recorded before and after treatment to detect changes in cortical activity which may reflect expected treatment effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2020
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2020
CompletedFirst Posted
Study publicly available on registry
March 2, 2020
CompletedStudy Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedMarch 26, 2020
March 1, 2020
1.8 years
February 25, 2020
March 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
NEPSY-II Neuropsychological Battery
Assessment of executive functions, language, memory and visuo-spatial skills Subscales (all subscales range from 1 to 19 scalar scores): * Design fluency, raw score 0/70 * Auditory attention, 0/30 and Response Set 0/36 * Inhibition (denomination 0/80 - 0/360') (inhibition 0/80 - 480') (switching 0/80 - 480') REVERSE (higher raw scores indicate worse perfomance) * Animal sorting, 0/12 * Word generation, 0/75 * Memory for faces, 0/32 * Word list interference (repetition 0/20; recall 0/40) * Imitating hand position, (0/24) * Visuo-motor precision (0/307; 0/360') REVERSE (higher raw scores indicate worse perfomance) * Manual motor sequences, 0/60 * Affect recognition, 0/35 * Design copying (general 0/21; motor 0/42; global 0/42; local 0/36; total specific 0/120) * Picture puzzles, 0/20 * Geometric puzzles, 0/40
baseline
Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV)
Assessment of general intellectual ability. Indexes (higher T scores indicate better perfomance for all indexes) * Verbal Comprehension Index (40/160) * Fluid Reasoning Index (40/160) * Working Memory Index (40/160) * Processing Speed Index (40/160) * Full Scale IQ (40/160)
baseline
NEPSY-II Neuropsychological Battery (change)
Assessment of executive functions, language, memory and visuo-spatial skills
within 1 week after intervention
NEPSY-II Neuropsychological Battery (change)
Assessment of executive functions, language, memory and visuo-spatial skills
3 month after intervention
Secondary Outcomes (15)
Child Behavior Checklist (CBCL) (parent compiled for 6-18 years old participants)
baseline
Youth Self Report (CBCL self-report version for 11-18 years old participants)
baseline
The Children's Quality of Life (TACQOL)
baseline
Behavior Rating Inventory of Executive Function (BRIEF-2) (parent compiled for 5-10 years old participants; self-report version for 11-18 years old participants)
baseline
Theta/beta ratio
baseline
- +10 more secondary outcomes
Study Arms (2)
Home rehabilitation training
EXPERIMENTALHome rehabilitation training
Home control activity
ACTIVE COMPARATORHome control activity
Interventions
The rehabilitation training will be provided via Lumosity platform. Participants will be asked to play computer video-games aimed at strengthening specific sub-functions pertaining to the macro area of executive functions for 30 minutes a day, 5 days a week, for a total of 8 weeks. Specifically, 20 games out of a total of 64 available games provided by the platform have been selected. The selected games are aimed at training 4 cognitive skills: memory, attention, cognitive flexibility and problem solving. In particular, 5 different games were chosen for each cognitive ability.
The control group will watch a series of animated / TV shows suitable for the sample age, again for 30 minutes a day, 5 days a week, for 8 weeks. The videos will be provided by the experimenter and participants will watch them on their personal computer. At the end of each videos, participants will answer a series of multiple-choice questions aimed at evaluating the attention deployed to the content of the videos.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of non-symptomatic epilepsy;
- Absence of intellectual disability (total IQ\> 70);
- Absence of significant visual, auditory or motor impairments that may prevent the use of the computerized training;
- Basic ability to use PC.
You may not qualify if:
- Presence of psychiatric comorbidity and / or behavioral disturbances that may hamper the participation to training sessions;
- Diagnosis of photosensitive epilepsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandra Bardoni, MD, PhD
Scientific Institute, IRCCS E. Medea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2020
First Posted
March 2, 2020
Study Start
May 1, 2020
Primary Completion
February 28, 2022
Study Completion
February 28, 2022
Last Updated
March 26, 2020
Record last verified: 2020-03